0535 GMT - Microport is set to strengthen its financials through its listed subsidiary MicroPort CardioFlow's plans to acquire Microport CRM, Nomura analyst Jialing Zhang says in a note. The deal involves MP CardioFlow issuing around 3.95 billion new shares at HK$1.35 each to wholly acquire and merge with MicroPort CRM from its parent Microport. MicroPort currently holds a 50.13% stake in the cardiac rhythm management provider, which has been a drag on its profitability. Along with MicroPort's operational expense control over the past two years, the transaction is expected to improve the company's balance sheet, though Zhang advises investors to monitor the pace of sales recovery. Nomura maintains a neutral rating and a HK$8.81 target price on Microport's stock, which last closed at HK$13.79. (jason.chau@wsj.com)
(END) Dow Jones Newswires
October 01, 2025 01:35 ET (05:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.